The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Boyd Thomas A since 2005.
The trader's CIK number is 1327433.
At the time of the last reporting, Boyd Thomas A was the Sr. VP, Product Dev. of Progenics Pharmaceuticals Inc. (stock ticker symbol PGNX).
Also see all insider trading activities at Progenics Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2010 | PGNX | 0 | $0 | 2,409 | $13,818 | 11,064 | $47,664 |
| 2009 | PGNX | 0 | $0 | 2,000 | $9,468 | 13,879 | $76,946 |
| 2008 | PGNX | 0 | $0 | 0 | $0 | 14,295 | $120,183 |
| 2007 | PGNX | 0 | $0 | 18,000 | $449,854 | 25,049 | $421,862 |
| 2006 | PGNX | 0 | $0 | 17,750 | $471,094 | 17,199 | $267,101 |
| 2005 | PGNX | 0 | $0 | 750 | $14,887 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-07-01 | PGNX | Option Ex | 2,675 | 4.44 | 11,877 |
| 2010-06-22 | PGNX | Sale | 2,409 | 5.74 | 13,818 |
| 2010-04-01 | PGNX | Option Ex | 2,621 | 4.56 | 11,941 |
| 2010-04-01 | PGNX | Option Ex | 2,621 | 4.56 | 11,941 |
| 2010-01-04 | PGNX | Option Ex | 3,147 | 3.78 | 11,905 |
| 2009-10-01 | PGNX | Option Ex | 2,666 | 4.26 | 11,354 |
| 2009-07-01 | PGNX | Option Ex | 7,738 | 5.33 | 41,243 |
| 2009-06-23 | PGNX | Sale | 2,000 | 4.73 | 9,468 |
| 2009-04-01 | PGNX | Option Ex | 2,120 | 5.65 | 11,978 |
| 2009-01-02 | PGNX | Option Ex | 1,355 | 9.13 | 12,371 |
| 2008-10-01 | PGNX | Option Ex | 4,384 | 6.53 | 28,627 |
| 2008-10-01 | PGNX | Option Ex | 4,384 | 6.53 | 28,627 |
| 2008-07-01 | PGNX | Option Ex | 2,921 | 13.64 | 39,842 |
| 2008-04-01 | PGNX | Option Ex | 1,914 | 6.52 | 12,479 |
| 2008-01-02 | PGNX | Option Ex | 692 | 15.33 | 10,608 |
| 2007-10-01 | PGNX | Option Ex | 2,029 | 19.03 | 38,611 |
| 2007-10-01 | PGNX | Option Ex | 2,029 | 19.03 | 38,611 |
| 2007-08-15 | PGNX | Option Ex | 2,000 | 15.41 | 30,814 |
| 2007-08-15 | PGNX | Sale | 2,000 | 22.88 | 45,766 |
| 2007-07-16 | PGNX | Sale | 2,000 | 21.51 | 43,018 |
| 2007-07-16 | PGNX | Option Ex | 2,000 | 15.41 | 30,814 |
| 2007-07-02 | PGNX | Option Ex | 545 | 18.71 | 10,196 |
| 2007-06-15 | PGNX | Option Ex | 2,000 | 15.41 | 30,814 |
| 2007-06-15 | PGNX | Sale | 2,000 | 22.03 | 44,054 |
| 2007-05-15 | PGNX | Option Ex | 2,000 | 15.41 | 30,814 |
| 2007-05-15 | PGNX | Sale | 2,000 | 21.90 | 43,804 |
| 2007-04-16 | PGNX | Sale | 2,000 | 26.94 | 53,874 |
| 2007-04-16 | PGNX | Option Ex | 2,000 | 15.41 | 30,814 |
| 2007-04-16 | PGNX | Sale | 2,000 | 26.94 | 53,874 |
| 2007-04-16 | PGNX | Option Ex | 2,000 | 15.41 | 30,814 |
| 2007-04-02 | PGNX | Option Ex | 2,018 | 20.13 | 40,622 |
| 2007-03-15 | PGNX | Option Ex | 2,000 | 15.41 | 30,814 |
| 2007-03-15 | PGNX | Sale | 2,000 | 22.78 | 45,568 |
| 2007-02-15 | PGNX | Option Ex | 4,000 | 17.19 | 68,760 |
| 2007-02-15 | PGNX | Sale | 4,000 | 29.97 | 119,896 |
| 2007-01-03 | PGNX | Option Ex | 428 | 21.88 | 9,364 |
| 2006-12-15 | PGNX | Option Ex | 2,000 | 17.19 | 34,380 |
| 2006-12-15 | PGNX | Sale | 2,000 | 26.05 | 52,100 |
| 2006-11-15 | PGNX | Option Ex | 2,000 | 15.41 | 30,814 |
| 2006-11-15 | PGNX | Sale | 2,000 | 28.93 | 57,856 |
| 2006-10-02 | PGNX | Option Ex | 470 | 19.58 | 9,202 |
| 2006-07-03 | PGNX | Option Ex | 1,986 | 20.45 | 40,615 |
| 2006-06-21 | PGNX | Sale | 3,750 | 21.64 | 81,138 |
| 2006-04-03 | PGNX | Option Ex | 376 | 21.77 | 8,185 |
| 2006-02-15 | PGNX | Option Ex | 10,000 | 13.62 | 136,250 |
| 2006-02-15 | PGNX | Sale | 10,000 | 28.00 | 280,000 |
| 2006-01-03 | PGNX | Option Ex | 367 | 20.86 | 7,655 |
| 2005-06-20 | PGNX | Sale | 750 | 19.85 | 14,887 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Boyd Thomas A (Sr. VP, Product Dev. of Progenics Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.